Publications in collaboration with researchers from University of Kansas Cancer Center (1)

2022

  1. Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial

    The Lancet Haematology, Vol. 9, Núm. 1, pp. e14-e25